» Articles » PMID: 7890370

Activation of Human THP-1 Cells and Rat Bone Marrow-derived Macrophages by Helicobacter Pylori Lipopolysaccharide

Overview
Journal Infect Immun
Date 1995 Apr 1
PMID 7890370
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanism by which Helicobacter pylori, which has little or no invasive activity, induces gastric-tissue inflammation and injury has not been well characterized. We have previously demonstrated that water-extracted proteins of H. pylori are capable of activating human monocytes by a lipopolysaccharide (LPS)-independent mechanism. We have now compared activation of macrophages by purified LPS from H. pylori and from Escherichia coli. LPS was prepared by phenol-water extraction from H. pylori 88-23 and from E. coli O55. THP-1, a human promyelomonocytic cell line, and macrophages derived from rat bone marrow each were incubated with the LPS preparations, and cell culture supernatants were assayed for production of tumor necrosis factor alpha (TNF-alpha), prostaglandin E2 (PGE2), and nitric oxide. THP-1 cells showed maximal activation by the LPS molecules after cell differentiation was induced by phorbol 12-myristate 13-acetate. Maximal TNF-alpha and PGE2 production occurred by 6 and 18 h, respectively, in both types of cells. In contrast, NO was produced by rat bone marrow-derived macrophages only and was maximal at 18 h. The minimum concentration of purified LPS required to induce TNF-alpha, PGE2, and NO responses in both types of cells was 2,000- to 30,000-fold higher for H. pylori than for E. coli. Purified LPS from three other H. pylori strains with different polysaccharide side chain lengths showed a similarly low level of activity, and polymyxin B treatment markedly reduced activity as well, suggesting that activation was a lipid A phenomenon. These results indicate the low biological activity of H. pylori LPS in mediating macrophage activation.

Citing Articles

Trained Immunity and Trained Tolerance: The Case of Infection.

Dore M, Pes G Int J Mol Sci. 2024; 25(11).

PMID: 38892046 PMC: 11172748. DOI: 10.3390/ijms25115856.


glycan biosynthesis modulates host immune cell recognition and response.

Barrett K, Kassama F, Surks W, Mulholland A, Moulton K, Dube D Front Cell Infect Microbiol. 2024; 14:1377077.

PMID: 38572314 PMC: 10987845. DOI: 10.3389/fcimb.2024.1377077.


Effect of the polysaccharide capsule and its heptose on the resistance of Campylobacter jejuni to innate immune defenses.

Myles M, Barnawi H, Mahmoudpour M, Shlimon S, Chang A, Zimmermann D Microbiologyopen. 2024; 13(1):e1400.

PMID: 38375546 PMC: 10877309. DOI: 10.1002/mbo3.1400.


A Tripartite Efflux System Affects Flagellum Stability in .

Gibson K, Chu J, Zhu S, Nguyen D, Mrazek J, Liu J Int J Mol Sci. 2022; 23(19).

PMID: 36232924 PMC: 9570263. DOI: 10.3390/ijms231911609.


actively suppresses innate immune nucleic acid receptors.

Dooyema S, Noto J, Wroblewski L, Piazuelo M, Krishna U, Suarez G Gut Microbes. 2022; 14(1):2105102.

PMID: 35905376 PMC: 9341374. DOI: 10.1080/19490976.2022.2105102.


References
1.
Sanduja S, Mehta K, Xu X, Hsu S, Sanduja R, Wu K . Differentiation-associated expression of prostaglandin H and thromboxane A synthases in monocytoid leukemia cell lines. Blood. 1991; 78(12):3178-85. View

2.
Christman J, Christman B, Shepherd V, Rinaldo J . Regulation of alveolar macrophage production of chemoattractants by leukotriene B4 and prostaglandin E2. Am J Respir Cell Mol Biol. 1991; 5(3):297-304. DOI: 10.1165/ajrcmb/5.3.297. View

3.
Mai U, Perez-Perez G, Allen J, Wahl S, Blaser M, Smith P . Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med. 1992; 175(2):517-25. PMC: 2119134. DOI: 10.1084/jem.175.2.517. View

4.
Moran A, Helander I, Kosunen T . Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. J Bacteriol. 1992; 174(4):1370-7. PMC: 206434. DOI: 10.1128/jb.174.4.1370-1377.1992. View

5.
Muotiala A, Helander I, Pyhala L, Kosunen T, Moran A . Low biological activity of Helicobacter pylori lipopolysaccharide. Infect Immun. 1992; 60(4):1714-6. PMC: 257055. DOI: 10.1128/iai.60.4.1714-1716.1992. View